Drug-labels.com

Auro-Letrozole: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
2.5 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Auro-Letrozole

ABOUT THIS MEDICATION

What AURO-LETROZOLE is used for:

  • The adjuvant treatment of postmenopausal women

    with hormone receptor-positive early breast cancer;

  • The extended adjuvant treatment of hormone receptor

    positive early breast cancer in postmenopausal women who have received approximately 5 years of prior standard adjuvant tamoxifen therapy.

  • The first-line therapy in postmenopausal women with

    advanced breast cancer; and

  • The hormonal treatment of advanced metastatic breast

    cancer in women with natural or artificially-induced postmenopausal status, who have disease progression following antiestrogen therapy.

What does AURO-LETROZOLE do:

Estrogen is a normally occurring female sex hormone that stimulates normal breast tissue and the growth of some types of breast cancer. AURO-LETROZOLE is an aromatase inhibitor which acts by binding to aromatase, a substance needed to make estrogen. As a result, the production of estrogen and the growth of breast cancer are reduced.

What is adjuvant therapy:

Adjuvant therapy in breast cancer refers to treatment following breast surgery (the primary or initial treatment) in order to reduce the risk of recurrence. The purpose of adjuvant therapy with AURO-LETROZOLE is to treat hormone receptor-positive early breast cancer, after surgery, in postmenopausal women to reduce the risk of recurrence.

What is extended adjuvant therapy:

The purpose of extended adjuvant therapy with AURO-LETROZOLE is to treat hormone receptor-positive early breast cancer in postmenopausal women who have received approximately 5 years of prior standard adjuvant tamoxifen therapy in order to prevent recurrence. Treating breast cancer with AURO-LETROZOLE beyond the standard 5 years of hormone therapy is called "extended adjuvant therapy".

When it should not be used:

AURO-LETROZOLE should not be used in children and adolescents under 18 years of age.

Do not take AURO-LETROZOLE if you:

  • have ever had an unusual or allergic reaction to letrozole or any other ingredient in AURO-LETROZOLE;
  • still have menstrual periods;
  • are pregnant or breast-feeding, as AURO-

    LETROZOLE may harm your baby.

What the medicinal ingredient is:

Letrozole

What the nonmedicinal ingredients are:

AURO-LETROZOLE also contains the following non-medicinal ingredients needed to make the tablets: FD&C Yellow #6 aluminium lake, magnesium stearate, polyethylene glycol, polyvinyl alcohol, silicified microcrystalline cellulose, sodium starch glycollate, talc, titanium dioxide and yellow iron oxide.

What dosage forms it comes in:

AURO-LETROZOLE (letrozole) 2.5 mg tablets

AURO-LETROZOLE is supplied as film-coated tablets. The film-coated tablets are yellow and round biconvex. They are marked with “2.5” on one side and plain on the reverse side AURO-LETROZOLE is supplied in blister packs containing 30 tablets.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

AURO-LETROZOLE should be used under the supervision of a doctor experienced in the use of anti-cancer drugs.

AURO-LETROZOLE reduces blood estrogen levels which may cause a reduction in bone mineral density and a potential increase in bone loss (osteoporosis) and/or bone fractures.

The use of aromatase inhibitors, including AURO-LETROZOLE, may increase the risk of cardiovascular events compared to tamoxifen, such as heart attacks and stroke. Women at risk of heart disease should be carefully monitored by their doctor.

You should not use AURO-LETROZOLE if you may become pregnant, are pregnant and/or breastfeeding. There is a potential risk of harm to you and the fetus, including risk of fetal malformations. If you have the potential to become pregnant (this includes women who are perimenopausal or who recently

IMPORTANT: PLEASE READ

became postmenopausal), you should discuss with your doctor about the need for effective contraception.

If there is exposure to AURO-LETROZOLE during pregnancy, you should contact your doctor immediately to discuss the potential of harm to your fetus and potential risk for loss of the pregnancy.

AURO-LETROZOLE should not be used in children and adolescents under 18 years of age.

Before you take AURO-LETROZOLE:

Tell your doctor if you:

  • have a serious kidney or serious liver disease
  • are taking hormone replacement therapy
  • are taking other medication to treat your cancer
  • have a personal or family history of osteoporosis or have

    ever been diagnosed with low bone density or have a recent history of fractures (in order for your doctor to assess your bone health on a regular basis).

  • have a personal or family history of high blood cholesterol

    or lipid levels. AURO-LETROZOLE may increase lipid levels.

  • have or have had cardiovascular or heart disease including

    any of the following: heart attack, stroke or uncontrolled blood pressure. AURO-LETROZOLE may increase the risk of cardiovascular or heart diseases.

  • have pain in bones, or joints or muscles.

Driving a vehicle or using machinery:

AURO-LETROZOLE tablets are unlikely to affect your ability to drive a car or to use machinery. However, some patients may occasionally feel tired, dizzy, sleepy or experience visual disorders. If this happens, you should not drive or operate any tools or machinery until you feel normal again.

INTERACTIONS WITH THIS MEDICATION

Please tell your doctor or pharmacist if you are taking or have recently taken any other prescription or over-the-counter medicines, vitamins or natural health products during your treatment with AURO-LETROZOLE.

PROPER USE OF THIS MEDICATION

Usual dose:

The usual dosage is one tablet of AURO-LETROZOLE to be taken once daily. The tablet should be swallowed whole with a small glass of water. You can take AURO-LETROZOLE with or without food. It is best to take AURO-LETROZOLE at about the same time every day.

Overdose:

If overdosage is known or suspected, contact your doctor or the nearest poison control centre for advice immediately. Show the pack of tablets. Medical treatment may be necessary.

Missed Dose:

If you forget to take a dose of AURO-LETROZOLE, don't worry, take the missed dose as soon as you remember. However, if it is almost time for the next dose (e.g., within 2 or 3 hours), skip the missed dose and go back to your regular dosage schedule. Do not take a double dose to make up for the one that you missed.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, AURO-LETROZOLE can have some side effects. Most side effects that have been observed were mild to moderate. Check with your doctor if the unwanted effects do not go away during treatment or become bothersome.

Some side effects, such as hot flushes, hair loss or vaginal bleeding may be due to the lack of estrogen in your body.

Very common side effects (they affect more than 10 in every 100 patients)

  • hot flushes
  • night sweat
  • pain in bones and joints.

Common side effects (they affect between 1 to 10 in every 100 patients)

  • headache
  • rash
  • dizziness
  • generally feeling unwell
  • gastrointestinal disorders (such as, nausea, vomiting, indigestion, constipation, diarrhea)
  • increase in or loss of appetite
  • increased blood sugar (hyperglycaemia)
  • urinary incontinence
  • pain in muscles
  • bone loss (osteoporosis)
  • bone fractures
  • depression
  • weight increase
  • anxiety
  • insomnia
  • hair loss
  • fatigue
  • Increased sweating
  • high level of cholesterol (hypercholesterolemia).

Uncommon side effects (they affect between 1 to 10 in every 1000 patients)

  • nervous disorders (such as nervousness, irritability, drowsiness)
IMPORTANT: PLEASE READ
  • reduced sense of touch (dysaesthesia)
  • eye irritation
  • palpitations, rapid heart rate
  • raised blood pressure (hypertension)
  • dry skin, itchy rash (urticaria), rapid swelling of face,

    lips, tongue, throat (angioedema)

  • severe allergic reaction (anaphylactic reaction)
  • vaginal disorders (such as bleeding, discharge or

    dryness)

  • abdominal pain
  • joint stiffness (arthritis)
  • breast pain
  • fever
  • thirst, taste disorder, dry mouth
  • dryness of mucous membranes
  • weight decrease
  • urinary tract infection, increased frequency of urination
  • cough
  • abnormal liver function test results (blood test

    disorders).

If you notice any other side effects not listed in this leaflet, please tell your doctor or pharmacist.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Common

-Pain in the muscles, bones and joints;

-Joint stiffness;

-Persistent sad mood (i.e. depression)

√

√

√
Uncommon
  • Tightness or feeling of heaviness in the chest or pain radiating from your chest to your arms or shoulders, neck, teeth or jaw, abdomen or back (signs of angina pectoris or heart attack);
  • Numbness or weakness in arm or leg or any part of the body, loss of coordination, vision changes, sudden headache, nausea, loss of coordination, difficulty in speaking or breathing (signs of brain disease e.g. stroke)
  • Swelling and redness along a vein which is extremely tender and possibly painful when touched (signs of inflammation of a vein due to

√

√

√

√

√

√

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases

a blood clot, e.g.

thrombophlebitis),

  • Difficulty breathing, chest pain, fainting rapid heart rate, bluish skin discoloration (signs of blood clot

formation in the lung such as pulmonary

embolism),

  • Swelling of arms, hands, feet, ankles or other parts of the body (signs of oedema),
  • Swelling mainly of the face and throat (signs of allergic reaction)
  • Severe fever, chills or mouth ulcers due to infections (signs of low level of white blood cells),
  • Blurred vision (sign of cataract).
  • Yellow skin and eyes, nausea, loss of appetite, dark coloured urine (signs of hepatitis)
  • Rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever (signs of skin disorder)

√

√

√

√

√

√

√

√

√

√

√

√

This is not a complete list of side effects. For any unexpected effects while taking AURO-LETROZOLE, contact your doctor or pharmacist.

HOW TO STORE IT

Store your tablets in a dry place at room temperature 15 to 30 °C. Avoid places where the temperature may rise above 30°C. Protect from moisture.

Keep this medicine out of the reach and sight of children and pets.

Expiry date:

Do not take AURO-LETROZOLE after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month. Remember to take any unused medication back to your pharmacist.

IMPORTANT: PLEASE READ

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

……………………………………………………………….

  • Report online: www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701C Ottawa ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at

www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of the side effect, please contact your health care professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

Auro Pharma Inc.

3700 Steeles Avenue West, Suite # 402 Woodbridge, ON, L4L 8K8 CANADA

Call toll-free at 1-855-648-6681 www.auropharma.ca

Date of Preparation: May 08, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02404400

Revision date stated in the text: May 8, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Auro-Letrozole

Rx or OTC
Prescription (Rx)?
DIN 02404400
Schedule(s) PRESCRIPTION
Active ingredient(s) Letrozole 2.5 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L02 Endocrine therapy antineoplastic and immunomodulating agents
      1. L02B Hormone antagonists and related agents
        1. L02BG Aromatase inhibitors
          1. L02BG04 Letrozole
Company AURO PHARMA INC
Current status Cancelled Post Market
Current status date April 24, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.